- Home
- COCH vs PYPD Comparison
COCH vs PYPD Comparison
Compare COCH & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- PYPD
- Stock Information
- Founded
- COCH 1995
- PYPD 2008
- Country
- COCH United States
- PYPD Israel
- Employees
- COCH N/A
- PYPD N/A
- Industry
- COCH Blank Checks
- PYPD Medical/Dental Instruments
- Sector
- COCH Finance
- PYPD Health Care
- Exchange
- COCH Nasdaq
- PYPD Nasdaq
- Market Cap
- COCH 31.6M
- PYPD 36.0M
- IPO Year
- COCH N/A
- PYPD 2020
- Fundamental
- Price
- COCH $1.62
- PYPD $3.66
- Analyst Decision
- COCH Strong Buy
- PYPD Strong Buy
- Analyst Count
- COCH 2
- PYPD 5
- Target Price
- COCH $9.25
- PYPD $11.40
- AVG Volume (30 Days)
- COCH 30.6K
- PYPD 175.1K
- Earning Date
- COCH 08-11-2025
- PYPD 08-13-2025
- Dividend Yield
- COCH N/A
- PYPD N/A
- EPS Growth
- COCH N/A
- PYPD N/A
- EPS
- COCH N/A
- PYPD N/A
- Revenue
- COCH $212,000.00
- PYPD N/A
- Revenue This Year
- COCH $5.93
- PYPD N/A
- Revenue Next Year
- COCH $17.69
- PYPD N/A
- P/E Ratio
- COCH N/A
- PYPD N/A
- Revenue Growth
- COCH N/A
- PYPD N/A
- 52 Week Low
- COCH $1.21
- PYPD $2.30
- 52 Week High
- COCH $3.99
- PYPD $4.42
- Technical
- Relative Strength Index (RSI)
- COCH 58.19
- PYPD 65.03
- Support Level
- COCH $1.56
- PYPD $3.30
- Resistance Level
- COCH $1.80
- PYPD $3.87
- Average True Range (ATR)
- COCH 0.12
- PYPD 0.14
- MACD
- COCH 0.02
- PYPD 0.01
- Stochastic Oscillator
- COCH 60.00
- PYPD 86.84
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.